NOVARTIS AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 98 USD | -0.01% |
|
-2.00% | -2.00% |
| 27/05 | Novartis: positive phase III results in C3G | CF |
| 27/05 | Novartis: presented results for kidney disease | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NOVARTIS AG | Other Pharmaceuticals | -0.01% | -2.00% | -2.00% | -0.04% | +12.19% | 204B | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- NOVN Stock
- NVSEF Stock
- Charts Novartis AG
- Comparison Chart
